Chemically self-assembled antibody nanorings (CSANs): Design and characterization of an anti-CD3 IgM biomimetic

Engineering & Materials Science

• Nanorings 100%
• Antibodies 62%
• Biomimetics 59%
• Monoclonal antibodies 41%
• T-cells 39%
• Oxidoreductases 23%
• Blood 14%
• Chemical activation 13%
• Proteins 10%
• Nanoparticles 7%
• Macrophages 6%
• Liposomes 6%
• Cholesterol 5%
• Dimers 5%
• Oligonucleotides 5%
• Cell proliferation 5%
• Crystal structure 4%
• Escherichia coli 4%
• Radioisotopes 4%
• Polymerization 4%
• Fusion reactions 3%
• Experiments 1%

Medicine & Life Sciences

• Biomimetics 62%
• anti-IgM 61%
• Antibodies 27%
• Tetrahydrofolate Dehydrogenase 24%
• Monoclonal Antibodies 23%
• Blood Cells 14%
• T-Lymphocytes 13%
• Single-Chain Antibodies 11%
• T-Cell Antigen Receptor 9%
• Immunoglobulin M 8%
• Nanoparticles 7%
• Caveolins 6%
• Interleukin-2 Receptors 5%
• Oligonucleotides 4%
• Polymerization 4%
• Radioisotopes 4%
• Glycine 4%
• Liposomes 4%
• Methotrexate 4%
• Immunoglobulin A 4%
• Protein-Tyrosine Kinases 4%
• Actins 3%
• Leukemia 3%
• Immunoglobulin G 3%
• Proteins 3%
• Cholesterol 3%
• Escherichia coli 3%
• Down-Regulation 3%
• Macrophages 3%
• Cell Proliferation 2%
• Pharmaceutical Preparations 1%
• Therapeutics 1%

Chemical Compounds

• Nanoring 70%
• Dihydrofolates 20%
• Methotrexate 6%
• Protein 6%
• Radioisotope 5%
• Nanoparticle 5%
• Liposome 5%
• Tyrosine 5%
• Surface 3%
• Polymerization Reaction 3%
• Drug 2%
• Crystal Structure 2%